PLSH
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
May 2 closing price
Capitalization
5.43M
STEK
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
May 2 closing price
Capitalization
2.98M
Ad is loading...

PLSH vs STEK

Header iconPLSH vs STEK Comparison
Open Charts PLSH vs STEKBanner chart's image
PANACEA LIFE SCIENCES
Price$0.05
Change-$0.00 (-0.00%)
Volume$5K
Capitalization5.43M
Stemtech
Price$0.02
Change-$0.00 (-0.00%)
Volume$268.99K
Capitalization2.98M
PLSH vs STEK Comparison Chart
Loading...
STEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLSH vs. STEK commentary
May 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLSH is a Hold and STEK is a Hold.

Ad is loading...
COMPARISON
Comparison
May 03, 2025
Stock price -- (PLSH: $0.05 vs. STEK: $0.02)
Brand notoriety: PLSH and STEK are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PLSH: 42% vs. STEK: 100%
Market capitalization -- PLSH: $5.43M vs. STEK: $2.98M
PLSH [@Pharmaceuticals: Other] is valued at $5.43M. STEK’s [@Pharmaceuticals: Other] market capitalization is $2.98M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLSH’s FA Score shows that 1 FA rating(s) are green whileSTEK’s FA Score has 0 green FA rating(s).

  • PLSH’s FA Score: 1 green, 4 red.
  • STEK’s FA Score: 0 green, 5 red.
According to our system of comparison, PLSH is a better buy in the long-term than STEK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STEK’s TA Score shows that 4 TA indicator(s) are bullish.

  • STEK’s TA Score: 4 bullish, 2 bearish.

Price Growth

PLSH (@Pharmaceuticals: Other) experienced а +44.05% price change this week, while STEK (@Pharmaceuticals: Other) price change was -6.12% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.04%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was -7.03%.

Reported Earning Dates

STEK is expected to report earnings on Apr 17, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (+2.04% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLSH($5.43M) has a higher market cap than STEK($2.98M). STEK has higher P/E ratio than PLSH: STEK (1.05) vs PLSH (0.00). PLSH YTD gains are higher at: 113.200 vs. STEK (-50.324). STEK (-4.36M) and PLSH (-4.49M) have comparable annual earnings (EBITDA) . PLSH has more cash in the bank: 998K vs. STEK (343K). STEK has less debt than PLSH: STEK (1.15M) vs PLSH (19.3M). STEK has higher revenues than PLSH: STEK (4.54M) vs PLSH (1.84M).
PLSHSTEKPLSH / STEK
Capitalization5.43M2.98M182%
EBITDA-4.49M-4.36M103%
Gain YTD113.200-50.324-225%
P/E Ratio0.001.050%
Revenue1.84M4.54M41%
Total Cash998K343K291%
Total Debt19.3M1.15M1,677%
FUNDAMENTALS RATINGS
PLSH vs STEK: Fundamental Ratings
PLSH
STEK
OUTLOOK RATING
1..100
7853
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
39
Fair valued
PROFIT vs RISK RATING
1..100
10099
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
6292
P/E GROWTH RATING
1..100
2592
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PLSH's Valuation (38) in the null industry is in the same range as STEK (39). This means that PLSH’s stock grew similarly to STEK’s over the last 12 months.

STEK's Profit vs Risk Rating (99) in the null industry is in the same range as PLSH (100). This means that STEK’s stock grew similarly to PLSH’s over the last 12 months.

STEK's SMR Rating (94) in the null industry is in the same range as PLSH (100). This means that STEK’s stock grew similarly to PLSH’s over the last 12 months.

PLSH's Price Growth Rating (62) in the null industry is in the same range as STEK (92). This means that PLSH’s stock grew similarly to STEK’s over the last 12 months.

PLSH's P/E Growth Rating (25) in the null industry is significantly better than the same rating for STEK (92). This means that PLSH’s stock grew significantly faster than STEK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STEK
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
STEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BTLKX8.480.24
+2.91%
Baillie Gifford Intl Concntr Gr EqsK
RPFGX66.881.71
+2.62%
Davis Financial A
SCWCX53.111.04
+2.00%
American Funds SMALLCAP World C
MLVBX18.680.21
+1.14%
MFS Low Volatility Equity B
ASPIX26.74N/A
N/A
Alger Spectra I

PLSH and

Correlation & Price change

A.I.dvisor tells us that PLSH and SHPH have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLSH and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSH
1D Price
Change %
PLSH100%
+8.22%
SHPH - PLSH
25%
Poorly correlated
+1.32%
KHTRF - PLSH
25%
Poorly correlated
+0.52%
CNADF - PLSH
21%
Poorly correlated
N/A
VTRS - PLSH
20%
Poorly correlated
+2.13%
STEK - PLSH
8%
Poorly correlated
-5.51%
More

STEK and

Correlation & Price change

A.I.dvisor tells us that STEK and CNADF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STEK and CNADF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STEK
1D Price
Change %
STEK100%
-5.51%
CNADF - STEK
25%
Poorly correlated
N/A
BFRI - STEK
12%
Poorly correlated
+4.33%
HLNCF - STEK
11%
Poorly correlated
+3.35%
PLSH - STEK
8%
Poorly correlated
+8.22%
EAPIF - STEK
6%
Poorly correlated
N/A
More